Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

被引:323
作者
Brunstein, Claudio G. [1 ,2 ]
Miller, Jeffrey S. [1 ,2 ]
McKenna, David H. [3 ,4 ]
Hippen, Keli L. [1 ,5 ]
Defor, Todd E. [1 ,6 ]
Sumstad, Darin [1 ,4 ]
Curtsinger, Julie [1 ,5 ]
Verneris, Michael R. [1 ,5 ]
MacMillan, Margaret L. [1 ,5 ]
Levine, Bruce L. [7 ,8 ]
Riley, James L. [7 ,8 ]
June, Carl H. [7 ,8 ]
Le, Chap [6 ,9 ]
Weisdorf, Daniel J. [1 ,2 ]
McGlave, Philip B. [1 ,2 ]
Blazar, Bruce R. [1 ,5 ]
Wagner, John E. [1 ,5 ]
机构
[1] Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN USA
[2] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[3] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Mol & Cellular Therapeut Facil, Minneapolis, MN USA
[5] Univ Minnesota, Div Pediat Blood & Marrow Transplantat, Minneapolis, MN USA
[6] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[7] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[8] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[9] Univ Minnesota, Div Biostat, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
TRANSPLANTATION; EXPRESS; ADULTS;
D O I
10.1182/blood-2015-06-653667
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the safety and clinical outcomes of patients treated with umbilical cord blood (UCB)-derived regulatory T cells (Tregs) that expanded in cultures stimulated with K562 cells modified to express the high-affinity Fc receptor (CD64) and CD86, the natural ligand of CD28 (KT64/86). Eleven patients were treated with Treg doses from 3-100x10(6) Treg/kg. The median proportion of CD4(+)FoxP3(+)CD127(-) in the infused product was 87% (range, 78%-95%), and we observed no dose-limiting infusional adverse events. Clinical outcomes were compared with contemporary controls (n = 22) who received the same conditioning regimen with sirolimus and mycophenolate mofetil immune suppression. The incidence of grade II-IV acute graft-versus-host disease (GVHD) at 100 days was 9% (95% confidence interval [CI], 0-25) vs 45% (95% CI, 24-67) in controls (P=.05). Chronic GVHD at 1 year was zero in Tregs and 14% in controls. Hematopoietic recovery and chimerism, cumulative density of infections, nonrelapse mortality, relapse, and disease-free survival were similar in the Treg recipients and controls. KT64/86-expanded UCB Tregs were safe and resulted in low risk of acute GVHD.
引用
收藏
页码:1044 / 1051
页数:8
相关论文
共 19 条
[1]   Human Herpesvirus 6 Infection after Hematopoietic Cell Transplantation: Is Routine Surveillance Necessary? [J].
Betts, Brian C. ;
Young, Jo-Anne H. ;
Ustun, Celalettin ;
Cao, Qing ;
Weisdorf, Daniel J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (10) :1562-1568
[2]   Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease [J].
Brunstein, Claudio G. ;
Barker, Juliet N. ;
Weisdorf, Daniel J. ;
DeFor, Todd E. ;
Miller, Jeffrey S. ;
Blazar, Bruce R. ;
McGlave, Philip B. ;
Wagner, John E. .
BLOOD, 2007, 110 (08) :3064-3070
[3]   Adoptive Transfer of Umbilical Cord Blood-Derived Regulatory T Cells and Early Viral Reactivation [J].
Brunstein, Claudio G. ;
Blazar, Bruce R. ;
Miller, Jeffrey S. ;
Cao, Qing ;
Hippen, Keli L. ;
McKenna, David H. ;
Curtsinger, Julie ;
McGlave, Philip B. ;
Wagner, John E. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (08) :1271-1273
[4]   Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics [J].
Brunstein, Claudio G. ;
Miller, Jeffrey S. ;
Cao, Qing ;
McKenna, David H. ;
Hippen, Keli L. ;
Curtsinger, Julie ;
DeFor, Todd ;
Levine, Bruce L. ;
June, Carl H. ;
Rubinstein, Pablo ;
McGlave, Philip B. ;
Blazar, Bruce R. ;
Wagner, John E. .
BLOOD, 2011, 117 (03) :1061-1070
[5]   Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells [J].
Duhen, Thomas ;
Duhen, Rebekka ;
Lanzavecchia, Antonio ;
Sallusto, Federica ;
Campbell, Daniel J. .
BLOOD, 2012, 119 (19) :4430-4440
[6]   CD28 costimulation is essential for human T regulatory expansion and function [J].
Golovina, Tatiana N. ;
Mikheeva, Tatiana ;
Suhoski, Megan M. ;
Aqui, Nicole A. ;
Tai, Victoria C. ;
Shan, Xiaochuan ;
Liu, Ronghua ;
Balcarcel, R. Robert ;
Fisher, Nancy ;
Levine, Bruce L. ;
Carroll, Richard G. ;
Warner, Noel ;
Blazar, Bruce R. ;
June, Carl H. ;
Riley, James L. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (04) :2855-2868
[7]   Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity [J].
Hippen, Keli L. ;
Merkel, Sarah C. ;
Schirm, Dawn K. ;
Sieben, Christine M. ;
Sumstad, Darin ;
Kadidlo, Diane M. ;
McKenna, David H. ;
Bromberg, Jonathan S. ;
Levine, Bruce L. ;
Riley, James L. ;
June, Carl H. ;
Scheinberg, Phillip ;
Douek, Daniel C. ;
Miller, Jeffrey S. ;
Wagner, John E. ;
Blazar, Bruce R. .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (83)
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]  
Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO
[10]  
2-M